Resources with keywords: ECMO HPS
Hantavirus Outbreak 2026
Johns Hopkins Medicine
14 May 2026
As of 18 May: 10 cases (8 lab-confirmed), 3 deaths. No confirmed U.S. Andes virus cases. Clinical laboratories advised to handle specimens from suspected HPS patients under BSL-2 enhanced precautions (Class II BSC, respirator). Andes virus is NOT a U.S. Select Agent, but laboratory directors should review biosafety risk assessments for specimen processing. Serology (IgM/IgG ELISA) and RT-PCR are diagnostic methods of choice; CDC DHCPP available for testing support.
